Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06495021 · ClinicalTrials.gov registry record · NA

How OMT Benefits Newly Diagnosed Patients With Respiratory Illness When Given Alongside Other Standard Care.

A NA study of Pneumonia and Respiratory Tract Infections, sponsored by Geisinger Clinic.

Recruiting
Registry status
NA
Development phase
68
Enrollment target
1
Study location

NCT06495021: Recruiting NA study of Pneumonia and Respiratory Tract Infections, sponsored by Geisinger Clinic.

NCT06495021 is a NA study of Pneumonia and Respiratory Tract Infections that is actively recruiting participants, run by Geisinger Clinic. The registered enrollment target is 68 participants, below the 4,518-participant average among 47 other Pneumonia trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06495021, a NA study of Pneumonia and Respiratory Tract Infections, is actively recruiting participants, sponsored by Geisinger Clinic.

RECRUITING
Registry status
NA
Development phase
68 participants
Enrollment target
1
Study location

Study Summary

This study is to see Osteopathic Manipulative Therapy, or OMT, can aid in treating patients being seen for respiratory illness and associated symptoms. The hypothesis is that the addition of OMT therapy, alongside other standard care (such as a medication), can help lessen patient symptoms sooner than just other treatment alone, and the duration of the condition will shorten as well.

Primary Outcome

Survey given to patients will provide feedback to capture their symptom severity at the time of diagnosis and 5 days post-diagnosis

Interventions

  • PROCEDURE Lymphatic Pump Osteopathic Manipulative Therapy

Study Locations (1)

Pennsylvania

  • Geisinger 65-Forward, Buckhorn - Bloomsburg

Trial Details

FieldValue
Enrollment Target 68 participants
Start Date 2024-12-31
Est. Completion 2026-06
Phase NA
Geisinger Clinic

107 total trials

What NCT06495021 shows while recruiting

NCT06495021 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 68 participants, a relatively small participant target, below the 4,518-participant average among 47 other Pneumonia trials with a reported enrollment target (98% lower).

The record links to 5 conditions, with Pneumonia appearing as the primary indexed condition, and to 1 intervention - of which Lymphatic Pump Osteopathic Manipulative Therapy is the first listed.

NCT06495021 reports a single indexed study location in Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT06495021 about?

NCT06495021 is a clinical study titled "How OMT Benefits Newly Diagnosed Patients With Respiratory Illness When Given Alongside Other Standard Care.". This study is to see Osteopathic Manipulative Therapy, or OMT, can aid in treating patients being seen for respiratory illness and associated symptoms. The hypothesis is that the addition of OMT therapy, alongside other standard care (such as a medication), can help lessen patient symptoms sooner th...

What is the current status of trial NCT06495021?

This trial is currently recruiting. It is a NA study. The enrollment target is 68 participants. The study started on 2024-12-31. Estimated completion is 2026-06.

What conditions does trial NCT06495021 study?

This clinical trial studies the following conditions: Pneumonia, Respiratory Tract Infections, Sinusitis, Respiratory Disease, Bronchitis.

What interventions are being tested in trial NCT06495021?

The interventions under investigation include: Lymphatic Pump Osteopathic Manipulative Therapy (PROCEDURE).

Who is sponsoring clinical trial NCT06495021?

This trial is sponsored by Geisinger Clinic, which has 107 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06495021 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Pneumonia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06495021's enrollment target sits among peer trials

68 32nd of 47 higher than 16 of 47 other Pneumonia trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Pneumonia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02044497 · 68 participants · Phase 4

    Population Pharmacokinetics and Pharmacogenomics of Oral Oxycodone in Pediatric Surgical Patients

  • NCT03779854 · 68 participants · Phase 2

    Naive T Cell Depletion for Preventing Chronic Graft-versus-Host Disease in Children and Young Adults With Blood Cancers Undergoing Donor Stem Cell Transplant

  • NCT03821246 · 68 participants · Phase 2

    Neoadjuvant Atezolizumab-Based Combination Therapy in Men With Localized Prostate Cancer Prior to Radical Prostatectomy

  • NCT04115514 · 68 participants · Phase 2

    Treatment of ARDS With Instilled T3

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06495021, the US trial registry maintained by the National Library of Medicine. NCT06495021 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.